Release
📈 Stocks
Translumina Initiates Global SPARX Trial for Drug-Coated Balloon Strategy
(just now)
Translumina begins the multinational SPARX trial, testing a drug-coated balloon-first approach to improve patient outcomes in cardiovascular interventions.